Laboratory Of Stock Fundamentals
| LH Stock | USD 240.17 2.32 0.98% |
Laboratory of fundamentals help investors to digest information that contributes to Laboratory's financial success or failures. It also enables traders to predict the movement of Laboratory Stock. The fundamental analysis module provides a way to measure Laboratory's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Laboratory stock.
As of now, Laboratory's EBIT is increasing as compared to previous years. The Laboratory's current Depreciation And Amortization is estimated to increase to about 609.9 M, while Gross Profit is projected to decrease to under 2 B. Laboratory | Select Account or Indicator |
Laboratory of Company Return On Asset Analysis
Laboratory's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Laboratory Return On Asset | 0.0396 |
Most of Laboratory's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Laboratory of is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Laboratory Total Assets
Total Assets |
|
Based on the latest financial disclosure, Laboratory of has a Return On Asset of 0.0396. This is 100.45% lower than that of the Health Care Providers & Services sector and 100.53% lower than that of the Health Care industry. The return on asset for all United States stocks is 128.29% lower than that of the firm.
Laboratory Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Laboratory's current stock value. Our valuation model uses many indicators to compare Laboratory value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Laboratory competition to find correlations between indicators driving Laboratory's intrinsic value. More Info.Laboratory of is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.73 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Laboratory of is roughly 1.37 . As of now, Laboratory's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Laboratory's earnings, one of the primary drivers of an investment's value.Laboratory Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Laboratory's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Laboratory could also be used in its relative valuation, which is a method of valuing Laboratory by comparing valuation metrics of similar companies.Laboratory is currently under evaluation in return on asset category among its peers.
Laboratory ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Laboratory's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Laboratory's managers, analysts, and investors.Environmental | Governance | Social |
Laboratory Fundamentals
| Return On Equity | 0.0543 | ||||
| Return On Asset | 0.0396 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 26.29 B | ||||
| Shares Outstanding | 83.64 M | ||||
| Shares Owned By Insiders | 0.32 % | ||||
| Shares Owned By Institutions | 94.81 % | ||||
| Number Of Shares Shorted | 2.03 M | ||||
| Price To Earning | 12.69 X | ||||
| Price To Book | 2.46 X | ||||
| Price To Sales | 1.58 X | ||||
| Revenue | 12.16 B | ||||
| Gross Profit | 4.39 B | ||||
| EBITDA | 1.35 B | ||||
| Net Income | 379.2 M | ||||
| Cash And Equivalents | 430 M | ||||
| Cash Per Share | 4.63 X | ||||
| Total Debt | 5.95 B | ||||
| Debt To Equity | 0.63 % | ||||
| Current Ratio | 1.73 X | ||||
| Book Value Per Share | 97.61 X | ||||
| Cash Flow From Operations | 1.33 B | ||||
| Short Ratio | 3.53 X | ||||
| Earnings Per Share | 5.26 X | ||||
| Price To Earnings To Growth | 0.51 X | ||||
| Target Price | 261.25 | ||||
| Number Of Employees | 67 K | ||||
| Beta | 1.04 | ||||
| Market Capitalization | 20.09 B | ||||
| Total Asset | 16.73 B | ||||
| Retained Earnings | 7.89 B | ||||
| Working Capital | 540.2 M | ||||
| Current Asset | 585.1 M | ||||
| Current Liabilities | 226.4 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 16.73 B | ||||
| Last Dividend Paid | 2.88 |
About Laboratory Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Laboratory of's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Laboratory using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Laboratory of based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 421.7 M | 442.8 M | |
| Total Revenue | 12.2 B | 12.8 B | |
| Cost Of Revenue | 8.8 B | 9.2 B | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Sales General And Administrative To Revenue | 0.21 | 0.20 | |
| Capex To Revenue | 0.04 | 0.04 | |
| Revenue Per Share | 139.63 | 146.61 | |
| Ebit Per Revenue | 0.06 | 0.06 |
Currently Active Assets on Macroaxis
Check out Laboratory Piotroski F Score and Laboratory Altman Z Score analysis. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 2.88 | Earnings Share 5.26 | Revenue Per Share 151.028 | Quarterly Revenue Growth 0.074 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.